thought call
progress key address long-term growth competit concern
despit view conserv guidanc remain bullish
share ahead readout year phase data pnh ahu
meaning updat sc program inde non-inferior soliri
enough approv commerci viabl given reduct
infus biosimilar threat soliri progress remain critic
protect termin valu base busi soliri growth moder
guid high-singl digit low-double-digit growth prior
quarter short-term issu given trial headwind remain bullish
gmg launch upsid driver inde launch gmg still
infancywith steadi stream patient flow initi process
expect revenu upsid cours year
focu us near term data realist bd rang view
potenti fund repatri cash could also support sentiment add anoth
 lever beyond complement favor risk/reward go data
anchor strong fundament maintain alexion top pick ow
rate pt
model chang given recent trend commentari adjust revenu
forecast reflect on-going headwind trial enrol price tailwind fx
also adjust opex tax assumpt see non-gaap ep
also ad risk adjust
sale begin see meaning opportun lengthen
franchis durat protect competit threat page detail
valuat continu valu alexion use npv sotp analysi assign
soliri sh strensiq kanuma
combin net cash support pt detail see page
quarterli annual ep usd
consensu number thomson reuter
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
growth soliri pnh/ahu addit upsid
like label expans refractori gmg
other addit fx headwind
macroeconom condit limit recent
return like diminish togeth
sale outlook support overweight rate
greater expect growth soliri current
indic ahu pnh gmg label expans
soliri nmo posit data
iv subcutan formul
mute uptak soliri current indic
failur expand soliri label poor phase
result emerg meaning
competit soliri beyond product perform
increas fx headwind
given recent trend commentari adjust revenu forecast reflect
on-going headwind trial enrol price tailwind fx see revenu
onward assum
risk-adjust sale driven pnh ahu new patient
cannib soliri patient also adjust opex op margin
prior tax assumpt vs prior see non-gaap
ep figur detail
price target base sum-of-th part npv analysi forecast sale
soliri strensiq kanuma includ termin valu
use discount rate soliri strensiq kanuma forecast period
think appropri reflect risk portfolio termin valu
assum less growth rate discount rate deriv valu
soliri share strensiq
kanuma combin net cash result total npv
share
except per op analysisoldnewoldnewr barclay
geoff meacham ph herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
